Valence Discovery Company
-Valence Discovery (“Valence”), is an AI-first design of novel chemistry against previously intractable biology.
Investors
Technology:
Artificial Intelligence, Machine Learning, Pharmaceutical, Therapeutics
Industry:
AI, Early Drug Development, Preclinical Development
Headquarters:
Montréal, Quebec, Canada
Founded Date:
2018-01-01
Employees Number:
11-50
Funding Status:
Seed
Investors Number:
13
Total Funding:
8527784
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-12-15
Last Funding Type:
Seed
Register and Claim Ownership